Thirty Days, Three Phases: Where CBD Fits Into a UK Menstrual Cycle — and Where It Doesn't
Photo: Urska.srsen, CC BY-SA 4.0, via Wikimedia Commons
The menstrual month is a useful organising idea for anyone trying to make sense of CBD marketing. It gives brands a structure: a follicular phase for energy, a luteal phase for mood, a bleed for pain. Products are named accordingly. The structure is persuasive, and the studies behind it are thin. That is not an argument against trying cannabidiol; it is an argument for approaching it the way you would approach any other over-the-counter purchase, with a clear idea of what you are testing and what you would accept as a result.
What the claims look like from the outside
Scan the UK market and you will find CBD positioned for premenstrual low mood, for cramps, for menstrual migraine, for 'hormonal balance'. Taken individually, each claim sounds modest. Taken together, they imply a body of evidence that does not currently exist in any robust form.
What we do have is a reasonable amount of preclinical work on cannabinoid signalling and inflammation, a modest number of small human studies in adjacent areas such as anxiety and sleep, and a great deal of anecdotal reporting. None of that amounts to a demonstration that CBD relieves dysmenorrhoea. Meanwhile, the evidence base for the ordinary alternatives — ibuprofen, paracetamol, heat, and where appropriate hormonal management — is considerably stronger and considerably older.
A useful discipline is to separate plausible from improbable. Plausible: some people find a calming product helpful in the days before a period, and a low-dose CBD product is a low-risk way to test that. Improbable: that a dropper of oil will resolve premenstrual dysphoric disorder, endometriosis pain, or a menstrual migraine with aura. Those are clinical matters, and they belong in a consultation, not a checkout.
Three phases, three different questions
The follicular phase and mid-cycle. There is little reason to expect a cannabinoid product to do anything specific here. If you are using CBD for general stress, keep the dose steady rather than escalating it, so that any change you notice later can be attributed to something.
The luteal phase. This is where most marketing lives. The honest position is that CBD has been studied for anxiety in general terms, not for premenstrual anxiety in particular, and that the products on sale — oils, gummies, drinks — differ substantially in dose and absorption. A gummy and a sublingual oil at the same stated milligram count are not interchangeable, and the label rarely explains why.
Menstruation itself. Cramps are driven largely by prostaglandins, which is why NSAIDs work and are recommended. CBD is not an NSAID and is not a substitute for one. A topical balm may feel soothing and carries very little systemic exposure; an ingested oil may produce a general sense of calm but should not be expected to switch off uterine cramping. If your pain is regularly severe enough to keep you off work or school, that is worth investigating rather than self-medicating around.
Why THC limits matter more here than elsewhere
The UK framework permits only trace tetrahydrocannabinol in CBD products, with a limit of 1 mg per container, and the hemp from which extracts are made is subject to a 0.2% threshold. In practice, products vary, and independent testing is the only way to know what is in a bottle.
For most buyers this is a compliance question. For some it is a practical one. If you are subject to workplace testing, drive for a living, or compete under anti-doping rules, an unverified product is a poor choice regardless of how it is marketed. Menstrual products are often taken for several consecutive days, which increases cumulative exposure — a further reason to buy from retailers who publish batch-level certificates of analysis rather than a generic PDF.
A cautious way to test
- Choose one product, one format, one strength. Do not begin with three things at once.
- Record your baseline across a full cycle before starting, using a simple written log rather than memory.
- Start at a low dose — the smallest that the label supports — and hold it for at least two cycles before adjusting. CBD is not a drug with a rapid onset and a clear ceiling; patience is the method.
- Keep the timing consistent, and note where in the cycle you are when you take it.
- Review honestly. If nothing changed after two cycles at a sensible dose, the product is not working for you, and continuing to buy it is a subscription, not a treatment.
The wider dosage questions are covered in our companion piece on approaching CBD without guesswork; here the essential point is that the menstrual cycle introduces a variable most dosing guides ignore. Hormonal fluctuation changes pain perception, sleep and mood on its own. Any test that does not account for the cycle will produce noise rather than signal.
Interactions, hormonal conditions and the GP question
CBD inhibits several cytochrome P450 enzymes, which is a technical way of saying it can alter how other medicines are handled. Warfarin, some epilepsy medications, certain antidepressants and immunosuppressants are the classic concerns; the picture with combined hormonal contraception is less clearly established but warrants a conversation rather than an assumption. If you take any regular prescription, a pharmacist is the fastest route to a considered answer, and they are generally willing to give one.
Conditions that deserve clinical input rather than a wellness product include suspected endometriosis, polycystic ovary syndrome, fibroids, thyroid disorders, and any cycle that has become markedly heavier, more painful or more erratic. The Food Standards Agency advises that CBD is not suitable for people who are pregnant or breastfeeding, and it is not intended for under-18s. Both points are relevant in a category where products are frequently pitched at women in their twenties and thirties without caveats.
The reasonable expectation
CBD across the menstrual month is best understood as a low-risk experiment in relaxation and routine, not a treatment for a gynaecological condition. Buy from a retailer that publishes testing, dose conservatively, keep a record, and give it two cycles. If it helps a little, that is a legitimate outcome. If it does not, stop — and if the underlying symptoms are significant, book the appointment you have been putting off.
